Mistletoe in Tumour
Therapy
B A S I C R E S E A R C
H A N D C L I N I C A
L P R A C T I C E
9th
M i s t l e t o e S y m p o s i u
m
4 - 6 November
2027
and
Integrated P r e
s e n c e and O n l i n e F u r
t h e r T r a i n i n g
P r a c t i s e o
f M i s t l e t o e T h e r a p
y
on 5 November 2027, 5.00 -
9.45 p.m.
Europäische Akademie Otzenhausen,
D-66620 Nonnweiler www.eao-otzenhausen.de/en/
1st A n n o u n c e m e n
t
Organizers:
Association of Anthroposophic Doctors in Germany,
Society for Phytotherapy,
Zentralverband der Ärzte für Naturheilverfahren u.
Regulationsmedizin (ZAEN)
Co-operation Partners:
APV The International Association for Pharmaceutical
Technology,
Deutsche Pharmazeutische Gesellschaft (German Pharmaceutical
Society),
European Society for Integrative Oncology,
Society for Medicinal Plant and Natural Product Research
Funding by foundations:
Karl and Veronica Carstens Foundation
Scientific Organizing
Committee:
Dr. Rainer Scheer, Niefern-Öschelbronn
(Director); Prof. Dr. Harald Matthes, Berlin
(Director); Prof. Dr. Susanne Alban, Kiel; Prof.
Dr. Reinhild Klein, Tübingen; Prof. Dr. Wolfgang Kreis, Hemhofen;
PD Dr. Ann-Kathrin Lederer, Ulm; PD Dr. Gero Leneweit,
Niefern-Öschelbronn; Dr. Emanuela Portalupi, Mailand (Italien);
Sabine Rieger, Balingen; Dr. Günther Spahn, Mainz; Dr. Rainer
Stange, Berlin.
Objectives:
Every four years, these symposiums on mistletoe-which we
organize-provide a forum for discussion that has been proven over
more than 30 years and serve as the foundation for a broad
scientific discourse and the exchange of clinical experiences. The
clinical session of this current symposium will
focus on Mistletoe in the Context of Modern
Immunotherapies and Multimodal Treatment
Approaches in Integrative Oncology and the Role of Mistletoe within
them. New findings and therapeutic approaches in
oncology continually open up new options for the use and further
development of mistletoe therapy. We cordially invite you to
attend.
Dear colleagues,
We kindly invite you to actively participate in the Mistletoe
Symposium and share your experiences and knowledge with your
colleagues. To do so, please submit your current scientific
contributions (short lectures and/or posters) on basic research and
the clinical application of Mistletoe in Tumour
Therapy.
The program for the 9th Mistletoe Symposium will be finalized in
mid-2027 based on your submitted contributions. Please find some
example topics listed below:
- Botany, physiology, pharmacy and
phytochemistry: appropriate standardisation,
assurance of pharmaceutical quality of mistletoe preparations,
their analytics and galenic.
- Immunology, pre-clinic, cytotoxicity, mode of
action profile of the active ingredients and total extracts
- Tumour-specific application: clinical efficacy
in malignant diseases, in benign tumours, for recurrence prevention
following tumour surgery, in defined precancerous disorders, and
the influence of mistletoe therapy on metastasis
- Posology, mode of application: Dosing regimens
and therapeutic range, effects of the route of administration on
the therapeutic range
- Immune parameters before and during mistletoe
therapy; immune status; follow-up parameters for
monitoring mistletoe therapy
- Clinical research and proof of
efficacy: clinical studies with mistletoe, objective
criteria for proof of efficacy, further developments in mistletoe
therapy
- Health services research data/Real World Data
on outcome, tolerability, safety and cost-effectiveness,
pharmacoeconomics
- Drug safety: analysis of side effects with
regard to effect and efficacy, type and frequency of adverse drug
reactions, pseudo allergic reactions
- Meta-analyses; systematic
reviews and their evaluation
- Regulatory issues
Overview presentations by invited speakers will
be given on selected topics (in bold).
The abstracts of all symposium contributions will be published
in the Journal of Integrative and Complementary Medicine
and will be available online at the symposium date. All symposium
participants will receive access to the abstracts and, upon
request, a printed copy.
Participation in the Mistletoe Symposium and the hybrid
training programme, cost contribution:
The Mistletoe Symposium will take place in person with a
training programme on Friday, which can also be attended online.
The number of participants and contributions in the scientific part
of the symposium is limited. The decision on the acceptance of
contributions and their form of presentation is the responsibility
of the Scientific Organizing Committee.
No event fees will be charged for participation
in the Mistletoe Symposium. Travel, accommodation and meals
on site must be paid for by each participant.
Language:
The symposium will be held in German. Simultaneous translation
into English will be provided for all presentations, including
contributions to the discussion.
Lectures may also be given in English, and posters should be
presented in English.
Publication of conference proceedings:
After the symposium, all contributions will be published in
conference proceedings as soon as possible. We therefore ask
authors to submit a print-ready
manuscript of their contribution by 31
January 2028.
The guidelines for authors of book articles are available at www.mistelsymposium.de.
Continuing education credits:
Certification and accreditation as a continuing education event
by the Saarland Medical Association (Landesärztekammer) and
Saarland Chamber of Pharmacists (Landesapothekerkammer) will also
be applied for the 9th Mistletoe Symposium.
For further information and for written registration
please contact:
Dr. Rainer Scheer, Carl Gustav Carus-Institut, Allmendstr. 55,
D-75223 Niefern-Öschelbronn
Tel. +49 7233 7043-118, Fax +49 7233 7043-110,
E-mail: rainer.scheer@carus-institut.de
Please follow the instructions on our
website www.mistelsymposium.de
Subject to alterations
Niefern-Öschelbronn, June 2026
Dr. Rainer Scheer